期刊文献+

膀胱癌高表达基因BCA7与其预后的相关性研究 被引量:1

The correlation between the expression of bladder cancer high-expressed gene BCA7 and the prognosis of bladder cancer
下载PDF
导出
摘要 目的分析膀胱癌高表达基因BCA7与患者预后的关系。方法免疫组化方法检测BCA7蛋白在122例膀胱癌组织及32例配对癌旁组织中的表达水平,应用统计学方法分析BCA7表达水平与患者的临床病理特征及预后的相关性。结果 BCA7蛋白在膀胱癌组织中染色评分明显高于配对癌旁组织(P<0.001)。122例标本中,32例(26.2%)为BCA7低表达,90例(73.8%)为BCA7高表达。BCA7高表达与膀胱癌组织学分级、病理分期有关(P<0.05),与患者性别、年龄、肿瘤大小、肿瘤数量无关(P均>0.05)。BCA7低表达患者平均生存时间为(52.6±2.4)个月,高于BCA7高表达患者的(40.9±2.2)个月(P=0.003)。结论 BCA7蛋白在膀胱癌中高表达,其表达水平与患者预后相关,可能是一个较为理想的膀胱癌预后标志物。 Objective To evaluate the relationship between BCA7 expression and prognosis of patients with bladder cancer. Methods BCA7 protein expression was detected in 122 cases of blad-der cancer and 32 cases of paired adjacent noncancerous tissues by immunohistochemistry.Statistical analysis was performed to analyse the relationship between expression of BCA7 and clinical patholog-ical characteristics,the correlation between BCA7 and prognosis of patients. Results The BCA7 staining score in tumor tissues was significantly higher than that in the corresponding adjacent nor-mal tissues (P 〈0.001).In 122 specimens,32 specimens (26.2%)showed low expression of BCA7 and 90 samples (73.8%)showed high expression of BCA7.High expression of BCA7 was correlated with tumor grade and T stage (P 〈0.05),but has nothing to do with gender,patients'age,tumor size,the number of tumor (P 〉0.05).The survival time of patients with low expression of BCA7 was longer than patients with high expression of BCA7,the difference was statistically significant (P =0.003). Conclusions BCA7 protein is up-regulated in bladder cancer tissues and its expres-sion level is related to the prognosis of patients with bladder cancer.It may be an ideal prognostic marker for patients of bladder cancer.
出处 《现代泌尿生殖肿瘤杂志》 2014年第1期37-41,共5页 Journal of Contemporary Urologic and Reproductive Oncology
基金 2012广东省自然科学基金(S2012010008365) 2013年深圳市科创委基础研究项目(JCYJ2013040-2113131201)
关键词 膀胱肿瘤 预后 BCA7基因 BCA7 Urinary bladder neoplasms Prognosis
  • 相关文献

参考文献15

  • 1Ploeg M, Aben KK, Kiemeney LA, et al. The present and future burden of urinary bladder cancer in the world[J]. World J Urol,2009,27(3) :289-293.
  • 2Jacobs BL, Lee CT, Montie JE. Bladder cancer in 2010: how far have we come? [J]. CA Cancer J Clin,2010,60(4) :244- 272.
  • 3Raghavan D, Shipley WU, Gamick MB, et al. Biology and management of bladder cancer[J]. N Engl J Med, 1990,322 (16):1129-1138.
  • 4Sternberg CN. The treatment of advanced bladder cancer[J]. Ann Onco1,1995,6(2) :113-126.
  • 5倪梁朝,来永庆,孟作为,吴雄辉,关志忱.膀胱癌高表达基因BCA7的表达分析[J].中华临床医师杂志(电子版),2011,5(11):3299-3301. 被引量:2
  • 6Liu D, Zhang Z, Kong CZ. High FOXM1 expression was as-sociated with bladder carcinogenesis[J]. Tumour Biol, 2013, 34(2) :1131-1138.
  • 7Black PC, Dinney CP. Bladder cancer angiogenesis and me- tastasis--translation from murine model to clinical trial[J]. Cancer Metastasis Rev, 2007, Z6 (3-4) : 623 634.
  • 8Shariat SF, Karakiewicz PI, Palapattu GS, et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consorti- um[J]. J Urol,2006,176(6 Pt 1):2414-2422.
  • 9Morgan TM, Keegan KA, Clark PE. Bladder cancer[J]. Curr ()pin Oncol,2011,23(3) =275-282.
  • 10Masood S, Sriprasad S, Palmer JH, et al. TIG3 bladder cancer-- indications for early cystectomy[J]. Int Urol Nephrol, 2004, a6 (1) :41-44.

二级参考文献3

  • 1许斌(综述),华立新(审校).膀胱癌流行病学进展[J].国际泌尿系统杂志,2007,27(4):469-476. 被引量:14
  • 2Gutiérrez Baos JL,del Henar Rebollo Rodrigo M,Antolín Juárez FM,et al.Usefulness of the BTA STAT Test for the diagnosis of bladder cancer. Urology . 2001
  • 3Seracchioli R,Mannini D,Colombo FM,et al.Cystoscopy-assisted laparoscopic resection of extramucosal bladder endometriosis. . 2002

共引文献1

同被引文献16

  • 1Siegel R, Naishactham D, Jemal A. Cancer statistics, 2012 [J]. CA: Cancer J C1in,2012.62(1):10 -29.
  • 2Ferlay J, Shin H, Bray F, et al. Eslimates of worldwide bur den of cancer in 2008: GLOBOCAN 2008[ J]. lnt J Canccr, 2010,127(12) :2893- 2917.
  • 3Yap KL, Kiyotani K, famura K. et al. Whole exome se quencing of muscle-invasive bladder cancer identifies recur rent mutations of UNCSC and prognoslic importance of DNA repair gene mutations on survival[J]. Clin Cancer Res, 2014.20(24):6605- 6617.
  • 4Gakls G, Schwentner C. Todenhofer T, et al. Currcnt status of molecular markers for prognostication and outcome in in vasive bladder cancer[J]. BJU Int,2012.110(2) :2;3- 237.
  • 5Pfister C, Moore L, Allard P, et al. Predictive value of eel cycle markers p53. MDM2, p21, and Ki-67 in superfieia bladder tumor recurrence[J]. Clin Cancer Res,1999,3(12): 4079- 4O84.
  • 6Golestani EB, Sanati MH, Houshmand M, et al. and prognostic significance of bcl- 2 and bax in the and clinical outcome of transitional bladder ce [J]. Cell J,2014,15(4):356- 363.
  • 7Besaratinia A, Tommasi S. Genotoxicily of tobacco smoke-de rived aromatic amines and bladder cancer: current slate of knowledge and future research directions[J]. FASEB J,2013,27(6) :2090-2100.
  • 8Rink M, Zabor EC, Furberg H, et al. Impact of Smoking and Smoking Cessation on Outcomes in Bladder Cancer Pa- tients Treated with Radical Cysteetomy[J]. Euro Urol, 2013,64(3) :456-464.
  • 9Liu S, Hou J, Zhang H, et al. The evaluation of the risk fac- tors for non-muscle invasive bladder cancer (NMIBC) recur- rence after transurethral resection (TURBt) in Chinese pop- ulation[J]. PLoS One,2015,10(4) : e0123617.
  • 10Yuan H, Chen X, Liu L, et al. Risk factors for intravesical recurrence after radical nephrouretereetomy for upper tracturothelial carcinoma: A meta-analysis[J]. Urol Oncol,2014, 32(7) : 989-1002.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部